Literature DB >> 10102136

Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease.

G H Borchert1, H Yu, G Tomlinson, M Giai, R Roagna, R Ponzone, L Sgro, E P Diamandis.   

Abstract

We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to alpha1-antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected in all cyst fluids and in about 75% of female sera. The median total PSA concentration in breast cyst fluid (bcf) is about 30 times higher than the median in the corresponding sera. Breast cyst fluid and serum PSA are not correlated with each other. Total serum PSA is inversely associated with patient age but the inverse association between bcf PSA and age is weak. Lower total PSA in bcf was seen in women who breast feed, and higher bcf PSA is associated with multiple cysts. Type I cysts (with a high K+/ Na+ ratio) tend to have higher total PSA than Type II cysts. All but three of the fractionated cyst fluids (75/78; 96%) had free PSA as the predominant molecular form. The most consistent finding of our study was the positive association between the cyst fluid K+/Na+ ratio and the free to bound PSA ratio. This association was confirmed by Spearman correlation as well as by Wilcoxon and chi-square analysis. Secretory/apocrine cysts (Type I) tend to have more total PSA and proportionally more free PSA than transudative/flattened cysts (Type II).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102136      PMCID: PMC6807928     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

1.  Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers.

Authors:  R A Ferguson; H Yu; M Kalyvas; S Zammit; E P Diamandis
Journal:  Clin Chem       Date:  1996-05       Impact factor: 8.327

Review 2.  New biological functions of prostate-specific antigen?

Authors:  E P Diamandis; H Yu
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

3.  Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer.

Authors:  D N Melegos; E P Diamandis
Journal:  Clin Biochem       Date:  1996-06       Impact factor: 3.281

4.  Prostate specific antigen in non-serum samples from women.

Authors:  X Filella; R Molina; J Alcover; E Casals; F Carmona; A M Ballesta
Journal:  Int J Biol Markers       Date:  1995 Oct-Dec       Impact factor: 3.248

5.  Prostate-specific antigen expression by various tumors.

Authors:  M Levesque; H Hu; M D'Costa; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

6.  Prostate specific antigen--a new constituent of breast cyst fluid.

Authors:  E P Diamandis; H Yu; C López-Otín
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age.

Authors:  H Yu; E P Diamandis; D J Sutherland
Journal:  Clin Biochem       Date:  1994-04       Impact factor: 3.281

8.  Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

Authors:  N Zarghami; L Grass; E P Diamandis
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

Authors:  N J Bundred; R R West; J O Dowd; R E Mansel; L E Hughes
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

10.  Prostate-specific antigen in serum of women with breast cancer.

Authors:  M Giai; H Yu; R Roagna; R Ponzone; D Katsaros; M A Levesque; E P Diamandis
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

View more
  4 in total

1.  Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Gazzanelli
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  The comparison of gene expression from multiple cDNA libraries.

Authors:  D J Stekel; Y Git; F Falciani
Journal:  Genome Res       Date:  2000-12       Impact factor: 9.043

3.  Prostate specific antigen in women with menstrual disturbances and fibrocystic mastopathy.

Authors:  S Radowicki; M Kunicki
Journal:  J Endocrinol Invest       Date:  2009-07-14       Impact factor: 4.256

Review 4.  Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

Authors:  F Mannello; G Gazzanelli
Journal:  Breast Cancer Res       Date:  2001-05-10       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.